HEALTHEQUITY INC
For the period ended Jul 31, 2024. Filed Sep 3, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2024 · Filed Sep 3, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other information
Rule 10b5-1 plan elections
On July 9, 2024, Robert Selander, chairman of our board of directors, entered into a Rule 10b5-1 trading arrangement (the “Selander Arrangement”). The Selander Arrangement provides for the sale, between October 9, 2024 and April 16, 2025, of up to 28,000 aggregate shares of the Company’s common stock held directly by Mr. Selander and the exercise of up to 65,000 stock options. The Selander Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
-39-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.